Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
In the context of perianal fistulizing Crohn's disease (PFCD), ustekinumab (UST) trough concentrations play a critical role in predicting clinical and radiological remission. A recent study has identified...
The novel antibiotic targeting inflammatory bowel disease (IBD) is called enterololin, and it represents a groundbreaking achievement in medical research, combining cutting-edge artificial intelligence (AI) with pharmacological science....
Extended risankizumab (RZB) therapy has shown promising results for Crohn’s disease patients who fail to respond to the standard 12-week induction phase. Phase 3 trials (ADVANCE, MOTIVATE, FORTIFY)...
Fidaxomicin has emerged as a promising therapeutic candidate for intestinal fibrosis in Crohn’s disease, a condition where up to 50% of patients develop strictures due to excessive collagen...
The FACILE Classification represents a groundbreaking advancement in the way Inflammatory Bowel Disease (IBD), including Crohn's Disease (CD) and Ulcerative Colitis (UC), is categorized. Moving beyond traditional frameworks...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.